May 22, 2013
1 min read
Save

Alopecia areata related to high prevalence of comorbid conditions

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients with alopecia areata had a high prevalence of comorbid conditions, according to study results published today.

In a retrospective cross-sectional study, researchers identified 3,568 patients with alopecia areata (AA) seen in tertiary care hospitals in Boston between January 2000 and January 2011. Three hundred-fifty patients were randomly selected, and their medical records were reviewed to train and validate a novel artificial intelligence program. AA diagnoses were reconfirmed by free-text records, and after reviewing a 40-patient subset, the algorithm showed 93.9% validity.

The artificial intelligence program identified 2,115 patients with AA (mean age, 42 years; 61.7% women). Atopy (allergic rhinitis, asthma and/or eczema in 38.2% of patients and contact dermatitis and other eczema in 35.9%) was a common comorbid condition, along with mental health problems (depression or anxiety, 25.5%) and autoimmune diagnoses (thyroid disease, 14.6%; diabetes mellitus, 11.1%; inflammatory bowel disease, 6.3%; systemic lupus erythematosus, 4.3%; and psoriasis and psoriatic arthritis, 2.0%). Hyperlipidemia (24.5%), hypertension (21.9%) and anemia (19.6%) also displayed high prevalences.

When the same comorbid conditions were evaluated in 402 patients with psoriasis and psoriatic arthritis (mean age, 56 years; 49.3% women), notable differences in prevalences included atopy (27.9%), rheumatoid arthritis (32.3%) and hypertension (44.3%). There were significant differences in the associated comorbid conditions between the AA cohort and the psoriasis/psoriatic arthritis cohort (P<.001), according to Pearson chi-square test results.

“Physicians caring for patients with AA should be aware of the associated comorbid conditions, especially autoimmune-related disease, atopic diathesis and mental health problems, so that we can screen for them when clinically indicated,” the researchers concluded.

Disclosure: See the study for a full list of relevant disclosures.